- Home
- And More
Elon Musk Hits Back At Claims That He’s To Blame For Tesla’s Plunging Stock
Elon Musk has replied to claims that he’s the reason behind Tesla’s share price sharp decline this year – saying that soaring interest rates have sparked a broader market sell-off…
By – Rochdi RaisLatest news
Investors Could Earn Big from Stocks Early Next Year, Says Morgan Stanley’s Top Stock Picker
The S&P 500 will slump to a new a low early next year, offering US stock investors a…
By Rochdi RaisBiggest Market Movers Premarket: Nike, FedEx, Rite Aid and More
Check out the companies making headlines before the bell: Rite Aid (RAD) – Rite Aid jumped 8.4% in…
By Rochdi Rais$2.7M Award Against Landlord Upheld: Court Said She Showed Persistent Pattern of Bad Faith
USA Herald – In the case of Duncan v. Kihagi (2021) 68 Cal.App.5th 519, 284 Cal. Rptr. 3d…
By Samuel LopezCouple Sues Hot Air Balloon Company for Injuries Caused As Passengers
USA Herald – This is the case of T.H.E. Insurance Co. v. Melyndia Davis et al., in the…
By Samuel LopezCA Tenant Sues Landlord for Wrongful Eviction Over Illegal Pot Grow Operation
USA Herald – This is a case involving the tenant, Fengyi Joey Situ, a property owner by the…
By Samuel LopezAmber Heard settles with Johnny Depp on defamation case
The long Depp vs Heard saga is finally over with Amber Heard announcing her decision to settle the…
By Jackie AllenWizard World Re-Branded Fan Expo HQ scheduled for January 6 in New Orleans
The billion-dollar pop culture/fan industry continues to boom as the techno pandemic fades. Last year Fan Expo HQ…
By Jackie AllenDow Sheds 300 Points As Recession Fears Mount and Investors Hope for a Year-End Rally Are Dashed
Stocks plummeted Monday as recession fears soared and investors worried time is running out for a year-end rally.…
By Rochdi RaisMadrigal Pharmaceuticals Stock Skyrockets 200% After Positive Results for its Drug to Treat “Silent Disease”
Madrigal Pharmaceuticals’ stock skyrocketed more than 200% on Monday after the biotech firm shared positive results for its…
By Rochdi RaisMeta Could Pay an $11 Billion Fine to EU for Potential Breach of Antirust Policies
The European Union filed a complaint against Meta for a potential breach of antitrust policies. Meta stock slumped…
By Rochdi Rais